FrancophonIA/ELRC3.0 huggingface dataset:
English: • inject Hyrimoz 15-30 minutes after taking it out of the refrigerator for a more comfortable injection.
Slovenian: • zdravilo Hyrimoz injicirate 15-30 minut po tem, ko ste ga vzeli iz hladilnika, da bo občutek pri injiciranju prijetnejši.
English: If your doctor considers that methotrexate is inappropriate, Hyrimoz can be given alone.
Slovenian: Če vaš zdravnik presodi, da metotreksat ni primeren, lahko zdravilo Hyrimoz dobivate samo.
English: Hyrimoz can be taken together with methotrexate or certain disease-modifying anti-rheumatic agents (sulfasalazine, hydroxychloroquine, leflunomide and injectable gold preparations), corticosteroids or pain medications including non-steroidal anti-inflammatory drugs (NSAIDs).
Slovenian: Zdravilo Hyrimoz se lahko uporablja skupaj z metotreksatom ali nekaterimi imunomodulirajočimi antirevmatičnimi zdravili (sulfasalazinom, hidroksiklorokinom, leflunomidom in pripravki zlata za injiciranje), kortikosteroidi in zdravili proti bolečinam, vključno z nesteroidnimi protivnetnimi zdravili.
English: Should treatment be interrupted, Hyrimoz 40 mg every week or 80 mg every other week may be reintroduced (see section 5.1).
Slovenian: Če je potrebno z zdravljenjem prekiniti, lahko ponovno uvedete zdravljenje z zdravilom Hyrimoz z odmerkom 40 mg vsak teden ali 80 mg vsak drugi teden (glejte poglavje 5.1).
English: Physicians should exercise caution when considering the use of Hyrimoz in patients with a history of recurring infection or with underlying conditions which may predispose patients to infections, including the use of concomitant immunosuppressive medications.
Slovenian: Pri odločanju za uporabo zdravila Hyrimoz je potrebna previdnost pri bolnikih z anamnezo ponavljajoče se okužbe ali z osnovnimi boleznimi, ki lahko zvečajo nagnjenost k okužbam, vključno s sočasno uporabljenimi imunosupresivnimi zdravili.
English: • Hyrimoz can be used during breast-feeding.
Slovenian: • Zdravilo Hyrimoz se lahko uporablja med dojenjem.
English: What Hyrimoz looks like and contents of the pack
Slovenian: Izgled zdravila Hyrimoz in vsebina pakiranja
English: Consequently, Hyrimoz can be used during breastfeeding..
Slovenian: Posledično se zdravilo Hyrimoz lahko uporablja med dojenjem.
English: All patients should be advised to seek immediate medical attention if they develop signs and symptoms suggestive of blood dyscrasias (e.g. persistent fever, bruising, bleeding, pallor) while on Hyrimoz.
Slovenian: Vsem bolnikom je treba naročiti, naj nemudoma poiščejo zdravniško pomoč, če se jim med uporabo zdravila Hyrimoz pojavijo znaki ali simptomi krvnih diskrazij (npr. trajno zvišana telesna temperatura, podplutbe, krvavitve, bledica).
English: Prescribers should exercise caution in considering the use of Hyrimoz in patients with pre-existing or recent-onset central or peripheral nervous system demyelinating disorders; discontinuation of Hyrimoz should be considered if any of these disorders develop.
Slovenian: Pri odločanju za uporabo zdravila Hyrimoz pri bolnikih z že prej obstoječimi ali nedavno nastalimi demielinizirajočimi boleznimi osrednjega ali perifernega živčevja je potrebna previdnost; če se razvije katera od teh bolezni, je treba razmisliti o prenehanju zdravljenja z zdravilom Hyrimoz.
English: A patient who requires surgery while on Hyrimoz should be closely monitored for infections, and appropriate actions should be taken.
Slovenian: Bolnika, ki med zdravljenjem z zdravilom Hyrimoz potrebuje operacijo, je treba natančno nadzirati glede okužb in ustrezno ukrepati.
English: If you stop using Hyrimoz
Slovenian: Če ste prenehali uporabljati zdravilo Hyrimoz
English: Hyrimoz in combination with methotrexate is indicated for the treatment of active polyarticular juvenile idiopathic arthritis, in patients from the age of 2 years who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs).
Slovenian: Zdravilo Hyrimoz je v kombinaciji z metotreksatom indicirano za zdravljenje aktivnega poliartikularnega juvenilnega idiopatskega artritisa pri bolnikih od 2. leta starosti, ki se ne odzovejo ustrezno na eno ali več imunomodulirajočih antirevmatičnih zdravil.
English: Hyrimoz is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults and adolescents from 12 years of age with an inadequate response to conventional systemic HS therapy (see sections 5.1 and 5.2).
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje aktivne, zmerne do hude oblike hidradenitis suppurativa (acne inversa) pri odraslih in mladostnikih, starejših od 12 let, ki se ne odzovejo zadovoljivo na konvencionalno sistemsko HS zdravljenje (glejte poglavji 5.1 in 5.2).
English: Hyrimoz is indicated for the treatment of moderate to severe chronic plaque psoriasis in adult patients who are candidates for systemic therapy.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje zmerne do hude kronične psoriaze v plakih pri odraslih bolnikih, ki so kandidati za sistemsko zdravljenje.
English: If you forget to use Hyrimoz
Slovenian: Če ste pozabili uporabiti zdravilo Hyrimoz
English: Antibiotics may be continued during treatment with Hyrimoz if necessary.
Slovenian: Med zdravljenjem z zdravilom Hyrimoz lahko nadaljujete z antibiotičnim zdravljenjem, če je potrebno.
English: • If you have or develop demyelinating disease (a disease that affects the insulating layer around the nerves, such as multiple sclerosis), your doctor will decide if you should receive or continue to receive Hyrimoz.
Slovenian: Demielinizirajoča bolezen • Če imate ali pa se pri vas razvija demielinizirajoča bolezen (bolezen, ki prizadene izolacijsko plast okrog živcev, kot je multipla skleroza), bo zdravnik presodil, ali lahko dobivate zdravilo Hyrimoz.
English: Administration of Hyrimoz should be discontinued if a patient develops a new serious infection or sepsis, and appropriate antimicrobial or antifungal therapy should be initiated until the infection is controlled.
Slovenian: Če se bolniku pojavi nova resna okužba ali sepsa, je treba uporabo zdravila Hyrimoz prekiniti in uvesti ustrezno protimikrobno ali protimikotično zdravljenje, dokler okužba ni obvladana.
English: Fever, bruising, bleeding or looking pale
Slovenian: modrice, krvavitve, bledica.
English: - Your doctor will also give you a Patient Reminder Card, which contains important safety information that you need to be aware of before you are given Hyrimoz and during treatment with Hyrimoz.
Slovenian: Ta vsebuje pomembne varnostne informacije, s katerimi morate biti seznanjeni, preden prejmete zdravilo Hyrimoz in med zdravljenjem z njim.
English: Neurologic evaluation should be performed in patients with noninfectious intermediate uveitis prior to the initiation of Hyrimoz therapy and regularly during treatment to assess for pre-existing or developing central demyelinating disorders.
Slovenian: Pri bolnikih z neinfekcijskim intermediarnim uveitisom je treba pred začetkom zdravljenja z zdravilom Hyrimoz in redno med zdravljenjem opravljati nevrološko oceno, da se oceni že obstoječe ali razvijajoče se demielinizirajoče bolezni osrednjega živčevja.
English: Hyrimoz is indicated for the treatment of adults with severe axial spondyloarthritis without radiographic evidence of AS but with objective signs of inflammation by elevated CRP and / or MRI, who have had an inadequate response to, or are intolerant to nonsteroidal anti-inflammatory drugs.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje odraslih s hudim aksialnim spondiloartritisom brez radiografskega dokaza za AS, toda z objektivnimi znaki vnetja s povišanimi CRP in/ali MRI, ki so nezadostno reagirali na ali ne prenašajo nesteroidnih protivnetnih zdravil.
English: Hyrimoz is injected under the skin (subcutaneous use).
Slovenian: Zdravilo Hyrimoz se injicira pod kožo (subkutana uporaba).
English: Hyrimoz is indicated for the treatment of severe chronic plaque psoriasis in children and adolescents from 4 years of age who have had an inadequate response to or are inappropriate candidates for topical therapy and phototherapies.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje hude psoriaze v plakih pri otrocih in mladostnikih od 4. leta starosti, ki so se neustrezno odzvali na ali niso ustrezni kandidati za topikalno zdravljenje in fototerapije.
English: Hyrimoz is indicated for the treatment of non-infectious intermediate, posterior and panuveitis in adult patients who have had an inadequate response to corticosteroids, in patients in need of corticosteroid-sparing, or in whom corticosteroid treatment is inappropriate.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje neinfekcijskega intermediarnega, posteriornega uveitisa in panuveitisa pri odraslih bolnikih, ki se niso zadostno odzvali na zdravljenje s kortikosteroidi, pri bolnikih s potrebo po zmanjšani uporabi kortikosteroidov ali pri bolnikih, pri katerih je zdravljenje s kortikosteroidi neprimerno.
English: If these medicines do not work well enough, you will be given Hyrimoz.
Slovenian: Če ta zdravila ne bodo dovolj dobro delovala, boste dobili zdravilo Hyrimoz.
English: How to use Hyrimoz
Slovenian: Kako uporabljati zdravilo Hyrimoz
English: Hyrimoz is used to treat
Slovenian: Zdravilo Hyrimoz se uporablja za zdravljenje
English: Hyrimoz is indicated for the treatment of active and progressive psoriatic arthritis in adults when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje aktivnega in napredujočega psoriatičnega artritisa pri odraslih, če odziv na predhodno zdravljenje z imunomodulirajočimi antirevmatiki ni bil ustrezen.
English: • Do not give Hyrimoz to children with paediatric Crohn's disease below the age of 6 years.
Slovenian: • Zdravila Hyrimoz ne smete dati otroku s Crohnovo boleznijo, če je star manj kot 6 let.
English: Thus, it is not possible to use Hyrimoz for children who require less than a full 40 mg dose.
Slovenian: Zato zdravila Hyrimoz ni mogoče uporabljati pri otroci, ki potrebujejo manj kot polni odmerek 40 mg.
English: Figure A: Hyrimoz pre-filled syringe with needle guard and add-on finger flange
Slovenian: Slika A: Napolnjena injekcijska brizga zdravila Hyrimoz s ščitnikom za iglo in držalom
English: The Hyrimoz 40 mg pre-filled syringe should not be used in children or adolescents weighing less than 40 kg with Crohn's disease, since it is not possible to administer doses less than 40 mg.
Slovenian: Zdravila Hyrimoz 40 mg napolnjena injekcijska brizga ne smete uporabljati pri otrocih ali mladostnikih s Crohnovo boleznijo, ki tehtajo manj kot 40 kg, saj ni mogoče dati odmerka, manjšega od 40 mg.
English: Hyrimoz is intended for the treatment of the following inflammatory diseases:
Slovenian: Zdravilo Hyrimoz je namenjeno za zdravljenje vnetnih bolezni, opisanih spodaj:
English: Children and adolescents from 4 to 17 years of age weighing 30 kg or more The recommended dose of Hyrimoz is an initial dose of 40 mg, followed by 40 mg one week later.
Slovenian: Otroci in mladostniki, stari od 4 do 17 let, ki tehtajo 30 kg ali več Priporočeni odmerek zdravila Hyrimoz je začetni odmerek 40 mg, ki mu sledi 40 mg en teden kasneje.
English: Hyrimoz works by reducing this inflammation.
Slovenian: Zdravilo Hyrimoz deluje tako, da zmanjša tako vnetje.
English: Hyrimoz dose for paediatric patients with Crohn's disease
Slovenian: Odmerjanje zdravila Hyrimoz pri pediatričnih bolnikih s Crohnovo boleznijo
English: • You should consider the use of adequate contraception to prevent pregnancy and continue its use for at least 5 months after the last Hyrimoz treatment.
Slovenian: Nosečnost in dojenje • Premisliti morate o uporabi ustrezne kontracepcijske zaščite za preprečitev nosečnosti in z njo nadaljevati vsaj še 5 mesecev po zadnjem zdravljenju z zdravilom Hyrimoz.
English: • Do not give Hyrimoz to children with polyarticular juvenile idiopathic arthritis below the age of
Slovenian: • Zdravila Hyrimoz ne smete dati otroku s poliartikularnim juvenilnim idiopatskim artritisom, če je star manj kot 2 leti.
English: If these medicines do not work well enough, patients will be given Hyrimoz to treat their polyarticular juvenile idiopathic arthritis or enthesitis-related arthritis.
Slovenian: Če ta zdravila ne delujejo dovolj dobro, bolniki za zdravljenje poliartikularnega juvenilnega idiopatskega artritisa ali artritisa, povezanega z entezitisom, dobijo zdravilo Hyrimoz.
English: * Note: Hyrimoz is currently only available as 40 mg pre-filled syringe and 40 mg pre-filled pen.
Slovenian: * Opomba: Zdravilo Hyrimoz je trenutno na voljo samo v 40 mg napolnjeni injekcijski brizgi in 40 mg napolnjenem injekcijskem peresniku.
English: For patients who develop the signs and symptoms such as fever, malaise, weight loss, sweats, cough, dyspnoea, and / or pulmonary infiltrates or other serious systemic illness with or without concomitant shock an invasive fungal infection should be suspected and administration of Hyrimoz should be promptly discontinued.
Slovenian: Če se bolniku pojavijo znaki ali simptomi, kot so npr. zvišana telesna temperatura, splošno slabo počutje, hujšanje, znojenje, kašelj, dispneja in/ali pljučni infiltrati ali druga sistemska bolezen (s spremljajočim šokom ali brez njega), je treba posumiti na invazivno glivično okužbo.
English: • high blood measurements for white blood cells;
Slovenian: • visoke krvne vrednosti za bele krvne celice;
English: Non-serious allergic reactions associated with adalimumab were uncommon during clinical trials.
Slovenian: Z adalimumabom povezane alergijske reakcije, ki niso bile resne, so se v kliničnih študijah pojavljale občasno.
English: • For a more comfortable injection, take your pen out of the refrigerator 15 to 30 minutes before injecting Hyrimoz to allow it to reach room temperature.
Slovenian: • Da bo injiciranje prijetnejše, vzemite injekcijski peresnik iz hladilnika približno od 15 do 30 minut pred injiciranjem zdravila , da se ogreje na sobno temperaturo.
English: It is recommended that paediatric patients, if possible, be brought up to date with all immunisations in agreement with current immunisation guidelines prior to initiating Hyrimoz therapy.
Slovenian: Za pediatrične bolnike je priporočljivo, da pred začetkom zdravljenja z zdravilom Hyrimoz opravijo vsa cepljenja v skladu z veljavnimi smernicami za cepljenje, če je le mogoče.
English: When Hyrimoz therapy is initiated, a loading dose of 40 mg for patients < 30 kg or 80 mg for patients ≥ 30 kg may be administered one week prior to the start of maintenance therapy.
Slovenian: Na začetku zdravljenja z zdravilom Hyrimoz se lahko pri bolnikih < 30 kg uporabi polnilni odmerek 40 mg in pri bolnikih ≥ 30 kg polnilni odmerek 80 mg en teden pred začetkom vzdrževalnegazdravljenja.
English: If these medicines do not work well enough, you will be given Hyrimoz to reduce the signs and symptoms of your disease.
Slovenian: Če ta zdravila ne bodo dovolj dobro delovala, boste dobili zdravilo Hyrimoz za zmanjšanje znakov in simptomov vaše bolezni.
English: Disposing of used syringes” at the end of these Instructions for Use.
Slovenian: Odstranjevanje uporabljenih injekcijskih brizg” na koncu teh navodil za uporabo.
English: If you have rheumatoid arthritis and you do not receive methotrexate with your Hyrimoz therapy, your doctor may decide to give 40 mg adalimumab every week or 80 mg every other week.
Slovenian: Če imate revmatoidni artritis in če hkrati z zdravilom Hyrimoz ne dobivate metotreksata, vam bo zdravnik morda predpisal 40 mg adalimumaba vsak teden ali 80 mg vsak drugi teden.
English: Hyrimoz dose for patients with polyarticular juvenile idiopathic arthritis
Slovenian: Odmerjanje zdravila Hyrimoz pri bolnikih s poliartikularnim juvenilnim idiopatskim artritisom
English: Methotrexate should be continued during treatment with Hyrimoz.
Slovenian: Med zdravljenjem z zdravilom Hyrimoz je treba še naprej uporabljati metotreksat.
English: • that Hyrimoz treatment may increase the potential risks of o infections, including tuberculosis o cancer o nervous system problems o vaccinations
Slovenian: • obvestilo, da lahko zdravljenje z zdravilom Hyrimoz poveča tveganje o okužb, vključno s tuberkulozo; o raka;
English: The recommended Hyrimoz induction dose regimen for adult patients with moderately to severely active Crohn's disease is 80 mg at week 0 followed by 40 mg at week 2.
Slovenian: Priporočena shema odmerjanja zdravila Hyrimoz med indukcijo je pri odraslih bolnikih z zmerno do hudo, aktivno Crohnovo boleznijo 80 mg 0. teden in nato 40 mg 2. teden.
English: If these medicines do not work well enough, you will be given Hyrimoz to treat your rheumatoid arthritis.
Slovenian: Če ta zdravila ne delujejo dovolj dobro, boste za zdravljenje revmatoidnega artritisa dobili zdravilo Hyrimoz.
English: • Do not give Hyrimoz to children with paediatric plaque psoriasis or paediatric ulcerative colitis below the age of 4 years.
Slovenian: • Zdravila Hyrimoz ne smete dati otroku z luskavico v plakih ali ulceroznim kolitisom, če je star manj kot 4 leta.
English: It is recommended that the patient should use a topical antiseptic wash on their HS lesions on a daily basis during treatment with Hyrimoz.
Slovenian: Priporočljivo je, da med zdravljenjem z zdravilom Hyrimoz bolnik vsak dan uporablja topikalno antiseptično čistilno sredstvo za čiščenje lezij HS.
English: Ophthalmologists are advised to consult with an appropriate specialist before initiation of treatment with Hyrimoz (see section 4.4).
Slovenian: Oftalmologom se svetuje, da se pred začetkom zdravljenja z zdravilom Hyrimoz posvetujejo z ustreznim specialistom
English: The recommended dose of Hyrimoz for patients with Crohn's disease from 6 to 17 years of age is based on body weight (table 4).
Slovenian: Priporočeni odmerek zdravila Hyrimoz pri bolnikih s Crohnovo boleznijo, starih od 6 do 17 let, temelji na telesni masi (preglednica 4).
English: Hyrimoz can slow down the damage to the cartilage and bone of the joints caused by the disease and improve physical function.
Slovenian: Zdravilo Hyrimoz lahko upočasni okvaro sklepnega hrustanca in kosti, ki jo povzroča ta bolezen, in izboljšuje telesno delovanje.
English: Thus, it is not possible to administer Hyrimoz to paediatric patients that require less than a full 40 mg dose.
Slovenian: Zato zdravila Hyrimoz ni mogoče dajati pediatričnim bolnikom, ki potrebujejo odmerek, manjši od 40 mg.
English: Hyrimoz is used in adults to treat these conditions.
Slovenian: Zdravilo Hyrimoz se uporablja za zdravljenje teh stanj pri odraslih.
English: The recommended dose of Hyrimoz for adult patients with rheumatoid arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Slovenian: Priporočeni odmerek zdravila Hyrimoz za odrasle bolnike z revmatoidnim artritisom je 40 mg adalimumaba vsak drugi teden v enkratnem odmerku v subkutani injekciji.
English: Hyrimoz is administered every other week via subcutaneous injection.
Slovenian: Zdravilo Hyrimoz se odmerja vsak drugi teden v obliki subkutane injekcije.
English: Cartons contain 1 and 2 pre-filled syringes of Hyrimoz.
Slovenian: Škatle vsebujejo 1 in 2 napolnjeni injekcijski brizgi zdravila Hyrimoz.
English: Children, adolescents and adults with polyarticular juvenile idiopathic arthritis Children, adolescents and adults from 2 years of age weighing 30 kg or more The recommended dose of Hyrimoz is 40 mg every other week.
Slovenian: Otroci, mladostniki in odrasli s poliartikularnim juvenilnim idiopatskim artritisom Otroci, mladostniki in odrasli, starejši od 2 let, ki tehtajo 30 kg ali več Priporočeni odmerek zdravila Hyrimoz je 40 mg vsak drugi teden.
English: • It is important that you tell your baby's doctors and other health care professionals about your Hyrimoz use during your pregnancy before the baby receives any vaccine (for more information on vaccines see the “Warnings and precautions” section).
Slovenian: • Pomembno je, da obvestite zdravnika vašega dojenčka in druge zdravstvene delavce, da ste med nosečnostjo prejemali zdravilo Hyrimoz, preden bo vaš dojenček prejel katerokoli cepivo.
English: The recommended dose of Hyrimoz for patients with ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of AS and for patients with psoriatic arthritis is 40 mg adalimumab administered every other week as a single dose via subcutaneous injection.
Slovenian: Priporočeni odmerek zdravila Hyrimoz pri bolnikih z ankilozirajočim spondilitisom, aksialnim spondiloartritisom brez radiografskega dokaza za AS in pri bolnikih s psoriatičnim artritisom je 40 mg adalimumaba, apliciran v enkratni subkutani injekciji vsak drugi teden.
English: Hyrimoz 40 mg solution for injection in a single-use pre-filled syringe Hyrimoz is supplied in a single-use clear type I glass syringe with a rubber stopper and a stainless steel needle with an automatic needle guard with finger flange, rubber needle cap and plastic plunger, containing 0.8 ml solution.
Slovenian: Hyrimoz 40 mg raztopina za injiciranje v napolnjeni injekcijski brizgi za enkratno uporabo Zdravilo Hyrimoz je na voljo v napolnjeni injekcijski brizgi za enkratno uporabo iz prozornega stekla tipa I z gumijasto zaporko in z iglo iz nerjavečega jekla z avtomatskim ščitnikom za iglo z držalom, z gumijastim pokrovčkom za iglo in s plastičnim batom, ki vsebuje 0,8 ml raztopine.
English: EU/1/18/1286/003 6 pre-filled syringes (3 packs of 2)
Slovenian: EU/1/18/1286/003 6 napolnjenih injekcijskih brizg (3 pakiranja po 2)
English: Package leaflet: Information for the patient Hyrimoz 40 mg solution for injection in pre-filled syringe adalimumab This medicine is subject to additional monitoring.
Slovenian: Navodilo za uporabo Hyrimoz 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku adalimumab Za to zdravilo se izvaja dodatno spremljanje varnosti.
English: Hyrimoz is indicated for treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy including corticosteroids and 6-mercaptopurine (6-MP) or azathioprine (AZA), or who are intolerant to or have medical contraindications for such therapies.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje zmerno do hudo aktivnega ulceroznega kolitisa pri odraslih bolnikih, ki so se ne odzovejo zadostno na običajno zdravljenje, na primer na kortikosteroide in 6-merkaptopurin (6-MP) ali azatioprin (AZA), ali pa takšnega zdravljenja ne prenesejo oz. imajo zanj medicinske kontraindikacije.
English: • sensation disorders such as tingling, prickling or numbness;
Slovenian: • otežkočeno spanje; • motnje v občutenju kot so ščemenje, zbadanje ali omrtvelost;
English: Hyrimoz is indicated for treatment of moderately to severely active Crohn's disease in adult patients who have not responded despite a full and adequate course of therapy with a corticosteroid and / or an immunosuppressant; or who are intolerant to or have medical contraindications for such therapies.
Slovenian: Zdravilo Hyrimoz je indicirano za zdravljenje zmerno do hudo aktivne Crohnove bolezni pri odraslih bolnikih, ki se ne odzovejo na popoln in ustrezen ciklus zdravljenja s kortikosteroidom in/ali imunosupresivom, ali pa takšnega zdravljenja ne prenesejo oz. imajo zanj medicinske kontraindikacije.
English: • neurological infections (including viral meningitis);
Slovenian: • nevrološke okužbe (vključno z virusnim meningitisom); • okužba očesa;
English: Hyrimoz is used to treat rheumatoid arthritis in adults.
Slovenian: Zdravilo Hyrimoz se uporablja za zdravljenje revmatoidnega artritisa pri odraslih.
English: During treatment with Hyrimoz, other concomitant therapies (e.g., corticosteroids and / or immunomodulatory agents) should be optimised.
Slovenian: Med zdravljenjem z zdravilom Hyrimoz je treba optimizirati druge sočasne terapije (npr.
English: Children, adolescents and adults with enthesitis-related arthritis Children, adolescents and adults from 6 years of age weighing 30 kg or more The recommended dose of Hyrimoz is 40 mg every other week.
Slovenian: Otroci, mladostniki in odrasli z artritisom, povezanim z entezitisom Otroci, mladostniki in odrasli, starejši od 6 let, ki tehtajo 30 kg ali več Priporočeni odmerek zdravila Hyrimoz je 40 mg vsak drugi teden.